Companies › PYXS

PYXIS ONCOLOGY INC (PYXS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001782223 · EDGAR filings · Updated 2026-07-10

PYXIS ONCOLOGY INC (PYXS) has reported institutional ownership of 43.9%, with 77 institutional managers holding positions valued at $40.5M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-10 — SCHEDULE 13G filed
• 2026-07-10 — Initial insider ownership filed (Form 3)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Current report (8-K) filed
• 2026-07-02 — SCHEDULE 13G/A filed
• 2026-06-30 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PYXIS ONCOLOGY INC has 77 institutional holders and institutional ownership of 43.9%.

Insider activity

Insiders reported 4 transactions (0 buys, 3 sells) across 2 reporting insiders, with a net reported value of −$15.9K.

Data flags from SEC filings

Related companies

PULMONX CORP (LUNG) · LUCID DIAGNOSTICS INC (LUCD) · NANO X IMAGING LTD (NNOX) · SERA PROGNOSTICS INC (SERA) · ARMATA PHARMACEUTICALS INC (ARMP) · CARDIFF ONCOLOGY INC (CRDF)